Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Zogenix
Zogenix
(ZGNX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Benzocaine
hypertension
Aspartame
neoplasms
,
melanoma
,
overweight
,
weight loss
,
nutrition disorders
,
hemophilia b
,
sickle cell anemia
,
thalassemia
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
type 1 diabetes mellitus
,
transient ischemic attack
,
hypoxia
,
diabetic neuropathies
,
nephritis
,
knee osteoarthritis
,
osteoarthritis
,
diastolic heart failure
,
myocardial reperfusion
,
pituitary dwarfism
,
insulin resistance
,
cardiovascular diseases
,
endocrine system diseases
,
laron syndrome
,
growth disorders
,
latent autoimmune diabetes in adults
,
hemophilia a
,
dwarfism
,
dyslipidemias
,
heart failure
,
chronic renal insufficiency
,
kidney diseases
,
heart disease risk factors
,
inflammation
,
atherosclerosis
Perfosfamide
liver cirrhosis
,
fibrosis
,
hepatitis c
,
experimental liver cirrhosis
Nabiximols
pain
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use